No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs368038760 |
chr11:45414062-45414063 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
2 |
rs144594212 |
chr11:45414063-45414064 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs76212854 |
chr11:45414073-45414074 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs552121881 |
chr11:45414166-45414167 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs1545466 |
chr11:45414183-45414184 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
6 |
rs79652181 |
chr11:45414184-45414185 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs1545467 |
chr11:45414193-45414194 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
8 |
rs180685470 |
chr11:45414222-45414223 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs535628615 |
chr11:45414223-45414224 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs138605445 |
chr11:45414270-45414271 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs200723406 |
chr11:45414281-45414282 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs531810966 |
chr11:45414337-45414338 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs187568272 |
chr11:45414363-45414364 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs534580194 |
chr11:45414376-45414377 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs386753162 |
chr11:45414388-45414389 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs201105407 |
chr11:45414390-45414391 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs202024875 |
chr11:45414392-45414393 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs543458799 |
chr11:45414419-45414420 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs563434857 |
chr11:45414428-45414429 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs140270310 |
chr11:45414443-45414444 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs568374831 |
chr11:45414518-45414519 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs563646757 |
chr11:45414545-45414546 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs182319165 |
chr11:45414546-45414547 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs185969525 |
chr11:45414571-45414572 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs552086699 |
chr11:45414574-45414575 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs565603675 |
chr11:45414620-45414621 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs368227131 |
chr11:45414622-45414623 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs549842919 |
chr11:45414626-45414627 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs143347365 |
chr11:45414671-45414672 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs535157308 |
chr11:45414672-45414673 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs549082442 |
chr11:45414709-45414710 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs565722725 |
chr11:45414782-45414783 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs534536244 |
chr11:45414796-45414797 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs190487050 |
chr11:45414881-45414882 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs570737186 |
chr11:45414907-45414908 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs536959805 |
chr11:45414930-45414931 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs539861533 |
chr11:45415025-45415026 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs896331 |
chr11:45415035-45415036 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
39 |
rs542718325 |
chr11:45415042-45415043 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs559829858 |
chr11:45415047-45415048 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs573333341 |
chr11:45415057-45415058 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs386753163 |
chr11:45415061-45415062 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs116171886 |
chr11:45415062-45415063 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs75274948 |
chr11:45415103-45415104 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs551299726 |
chr11:45415106-45415107 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs12271560 |
chr11:45415146-45415147 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
47 |
rs528918186 |
chr11:45415193-45415194 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs74827412 |
chr11:45415300-45415301 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs565816780 |
chr11:45415362-45415363 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs535770034 |
chr11:45415367-45415368 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|